Nucleus Software Exports Limited (NSE: NUCLEUS, BSE: 531209), a leading global provider of software products for banks and financial institutions today announced that its product FinnOneTM has been ranked 'World's No. 1 Selling Lending Software Product' by International Banking Systems (IBS), UK, in its annual Sales League Table for the year 2008.
Published by IBS Publishing, the IBS Sales League Table independently tracks financial product market and is based on a worldwide annual survey of sales of corporate, retail and private banking solutions. IBS Publishing is an independent research and publishing house dedicated to news, research and analysis covering banking operations and systems internationally.
This is the fourth consecutive year that FinnOneTM has been ranked amongst world's best selling lending software products; the ranking is based on the number of sales made in the calendar year. FinnOneTM, ranked best in the lending category, emerged a winner with 17 global sales for year 2008. With this recognition FinnOneTM further establishes its global leadership position.
FinnOne™, the flagship product of Nucleus Software, is a powerhouse of seamlessly integrated applications, designed to provide operational support, risk management and decision-making support to banks and financial services companies. The FinnOne™ suite provides solutions for the asset as well as liability sides of business in addition to account management, core financial accounting, risk management, document management, and customer services. FinnOne™ also supports multi-branch, multi-currency, multi-product, and bi-lingual implementations. FinnOne™ focuses on both, retail and corporate loans, thereby emerging as a comprehensive solution to back any line of the lending business.
On this occasion Vishnu Dusad, CEO & MD, Nucleus Software, said, “It's a matter of great pride to see FinnOneTM recognized as 'World's No.1 Selling Lending Software Product'. At Nucleus we are passionately focused on creating world-class intellectual property for a global market. Nucleus' vision is to be leading global end-to-end products & solution provider; a customer-oriented global organization committed to the highest level of quality for its products and services. A trustworthy, customer oriented organization...an open and warm environment where everyone is respected, listened to encouraged to excel...actively creating and exploring opportunity for the growth of our customers and our organization. As one of the largest IP creators in the country this recognition will only propel us to continue our quest to take technology to the next level and our commitment to offer our customers across the globe a distinct business advantage.”
About IBS Publishing:
For seventeen years IBS Publishing has been the definitive source of news, research and analysis covering banking operations and systems internationally. In addition to their monthly IBS Journal and CFS Journal, they publish a range of reports, case studies and directories. Both the journal and their publications contains no advertorial or copy submitted by interested parties; they are written entirely by their in-house journalists with input from professional independent freelance writers based around the globe.
About Nucleus Software Exports Limited:
Nucleus Software is a leading software powerhouse providing innovative and pioneering software solutions for Banks and Financial organizations globally. Nucleus Software offers a host of competitive IT solutions and consultancy services designed to support the whole spectrum of business offerings across retail banking, corporate banking, cards and cash management. With over 150 customers across the globe, the company is consistently innovating with cutting edge and industry driven products in the domain. Nucleus Software is listed on the National Stock Exchange and Bombay Stock Exchange in India. For more information, visit www.nucleussoftware.com
Safe Harbor:
Certain statements in this release concerning our future growth prospects are forward-looking statements, which involve a number of risks and uncertainties that could cause actual results to differ materially from those in such forward-looking statements. The risks and uncertainties relating to these statements include, but are not limited to, risks and uncertainties regarding the success of our investments, risks and uncertainties regarding fluctuations in earnings, our ability to manage growth, our ability to successfully implement our strategy, our research and development efforts, changes in the value of the Rupee and other currency changes, intense competition in IT and consulting services including those factors which may affect our cost advantage, wage increases in India, our ability to attract and retain highly skilled professionals, time and cost overruns on fixed-price, fixed-time frame contracts, client concentration, restrictions on immigration, industry segment concentration, our ability to manage our international operations, reduced demand for technology in our key focus areas, disruptions in telecommunication networks or system failures, our ability to successfully complete and integrate potential acquisitions, liability for damages on our service contracts, withdrawal of governmental fiscal incentives, political instability and regional conflicts, legal restrictions on raising capital or acquiring companies outside India, and unauthorized use of our intellectual property and general economic conditions affecting our industry. Nucleus may, from time to time, make additional written and oral forward-looking statements, including statements contained in the company’s filings with the Securities and Exchange Board of India, Stock Exchange and our reports to shareholders. The company does not undertake to update any forward-looking statements that may be made from time to time by or on behalf of the company.
